Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Archana Upadhya, Khushwant S. Yadav & Ambikanandan Misra. (2021) Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I. Expert Opinion on Drug Delivery 18:1, pages 73-102.
Read now
Read now
Articles from other publishers (22)
Neeraj Choudhary, Sweta Bawari, Jack T. Burcher, Dona Sinha, Devesh Tewari & Anupam Bishayee. (2023) Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds. Cancers 15:15, pages 3980.
Crossref
Crossref
Shiqi Nong, Xiaoyue Han, Yu Xiang, Yuran Qian, Yuhao Wei, Tingyue Zhang, Keyue Tian, Kai Shen, Jing Yang & Xuelei Ma. (2023) Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm 4:2.
Crossref
Crossref
Aurimas Stulpinas, Matas Sereika, Aida Vitkeviciene, Ausra Imbrasaite, Natalija Krestnikova & Audrone V. Kalvelyte. (2023) Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models. Frontiers in Oncology 12.
Crossref
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
205
411
.
Tanuja Yadav, Velisha Mehta, Nilam Bhusare, Meena Chintamaneni & Y. C. Mayur. 2023. Drug Repurposing for Emerging Infectious Diseases and Cancer. Drug Repurposing for Emerging Infectious Diseases and Cancer
111
158
.
Qing Ye, Justin Hickey, Kathleen Summers, Brianne Falatovich, Marieta Gencheva, Timothy D. Eubank, Alexey V. Ivanov & Nancy Lan Guo. (2022) Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. International Journal of Molecular Sciences 23:23, pages 14978.
Crossref
Crossref
Md Shahin Alam, Md Matiur Rahaman, Adiba Sultana, Guanghui Wang & Md Nurul Haque Mollah. (2022) Statistics and network-based approaches to identify molecular mechanisms that drive the progression of breast cancer. Computers in Biology and Medicine 145, pages 105508.
Crossref
Crossref
Yinggang Che, Dongbo Jiang, Leidi Xu, Yuanjie Sun, Yingtong Wu, Yang Liu, Ning Chang, Jiangjiang Fan, Hangtian Xi, Dan Qiu, Qing Ju, Jingyu Pan, Yong Zhang, Kun Yang & Jian Zhang. (2022) The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD. Frontiers in Immunology 13.
Crossref
Crossref
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, Marie Helene Errera, Hitesh Agrawal, Marco Lupidi & Jay Chhablani. (2022) Retinal toxicities of systemic anticancer drugs. Survey of Ophthalmology 67:1, pages 97-148.
Crossref
Crossref
Yugyung Jung, Minkook Son, Yu Ri Nam, Jongchan Choi, James R. Heath & Sung Yang. (2021) Microfluidic Single-Cell Proteomics Assay Chip: Lung Cancer Cell Line Case Study. Micromachines 12:10, pages 1147.
Crossref
Crossref
Andrea Gonzalez Rodriguez, Megan E. Schroeder, Joseph C. Grim, Cierra J. Walker, Kelly F. Speckl, Robert M. Weiss & Kristi S. Anseth. (2021) Tumor necrosis factor‐α promotes and exacerbates calcification in heart valve myofibroblast populations. The FASEB Journal 35:3.
Crossref
Crossref
Sitanshu S. Singh, Achyut Dahal, Leeza Shrestha & Seetharama D. Jois. (2020) Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy. Current Medicinal Chemistry 27:32, pages 5274-5316.
Crossref
Crossref
Jade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, Mahindra Makhija, Allison Berger, Todd Sells, Steve Stroud, David Hilton, Claire L. Adams & C Oliver Hanemann. (2020) The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma. Cancers 12:7, pages 1744.
Crossref
Crossref
Abdulaziz B. Hamid & Ruben C. Petreaca. (2020) Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers 12:4, pages 927.
Crossref
Crossref
Xiang Chen, Yi Guo & Xin Chen. (2020) iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research. Genomics, Proteomics & Bioinformatics 18:2, pages 150-160.
Crossref
Crossref
Andrijana Meščić Macan, Nataša Perin, Silvio Jakopec, Marija Mioč, Marijana Radić Stojković, Marijeta Kralj, Marijana Hranjec & Silvana Raić-Malić. (2020) Synthesis, antiproliferative activity and DNA/RNA-binding properties of mono- and bis-(1,2,3-triazolyl)-appended benzimidazo[1,2-a]quinoline derivatives. European Journal of Medicinal Chemistry 185, pages 111845.
Crossref
Crossref
Vipin Shankar Chelakkot, Jayoti Som, Ema Yoshioka, Chantel P. Rice, Suzette G. Rutihinda & Kensuke Hirasawa. (2019) Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy. British Journal of Cancer 121:9, pages 758-767.
Crossref
Crossref
Ying Cheng, Xingkai Wang, Xiangying Xia, Wei Zhang & Hongqi Tian. (2019) A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer. International Journal of Cancer 145:2, pages 586-596.
Crossref
Crossref
Erdem Bangi. 2019. The Drosophila Model in Cancer. The Drosophila Model in Cancer
237
248
.
Linlin Zhang & Shuangquan Yu. (2018) Role of miR‑520b in non‑small cell lung cancer. Experimental and Therapeutic Medicine.
Crossref
Crossref
MengMeng Xu, Michael Casio, Danielle E. Range, Julie A. Sosa & Christopher M. Counter. (2018) Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer. Clinical Cancer Research 24:17, pages 4271-4281.
Crossref
Crossref
B.M.E. Tullemans, J.W.M. Heemskerk & M.J.E. Kuijpers. (2018) Acquired platelet antagonism: off‐target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors. Journal of Thrombosis and Haemostasis 16:9, pages 1686-1699.
Crossref
Crossref